Preparation and biodistribution of [67Ga]-DTPA-gonadorelin in normal rats

  • A. R. Jalilian
  • S. Shanehsazzadeh
  • M. Akhlaghi
  • J. Garousi
  • S. Rajabifar
  • M. B. Tavakoli


Gonadorelin was successively labeled with [67Ga]-gallium chloride after residulation with freshly prepared cyclic DTPA-dianhydride. The best results of the conjugation were obtained by the addition of 1 mg of a gonadorelin to a glass tube pre-coated with DTPA-dianhydride (0.33 mg) at 25 °C with continuous mild stirring for 1 hour. Radio thin layer chromatography showed an overall radiochemical purity of >90% at optimized conditions after labeling. HPLC showed a radiochemical purity more than 95% (specific activity = 400–450 GBq/M). The stability of the radioconjugate was tested in presence of human serum at 37 °C. Preliminary in vivo studies in normal rats were performed to determine the biodistribution of the conjugate up to 48 hours. The breast and ovaries uptakes were significantly high in first 15-minute post injection which is in agreement with the other reports regarding the presence of specific GnRH receptors. This tracer can be used in detection of GnRH receptor biodistribution in various diseases and malignancies.


DTPA GnRH Agonist Radiochemical Purity GnRH Receptor Gonadorelin 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    A. V. Schally, A. Arimura, Y. Baba, R. M. Nair, H. Matsuo, T. W. Redding, L. Debeljuk, Biochem. Biophys. Res. Commun., 43 (1971) 393.CrossRefGoogle Scholar
  2. 2.
    H. Matsuo, Y. Baba, R. M. Nair, A. Arimura, A. V. Schally, Biochem. Biophys. Res. Commun., 43 (1971) 1334.CrossRefGoogle Scholar
  3. 3.
    Y. Baba, H. Matsuo, A. V. Schally, Biochem. Biophys. Res. Commun., 44 (1971) 459.CrossRefGoogle Scholar
  4. 4.
    G. Fink, Gonadotropin secretion and its control, in: The Physiology of Reproduction, E. Knobil, J. Neill (Eds), Raven Press, New York, 1988, p. 1349.Google Scholar
  5. 5.
    P. H. Seeburg, A. J. Mason, T. A. Stewart, K. Nikolics, Recent Progr. Horm. Res., 43 (1987) 69.Google Scholar
  6. 6.
    G. Tolis, D. Ackman, A. Stellos, A. Mehta, F. Labrie, A. T. A. Fazekas, A. M. Comaru-Schally, A. V. Schally, Proc. Natl. Acad. Sci. USA, 79 (1982) 1658.CrossRefGoogle Scholar
  7. 7.
    J. G. M. Klijn, Med. Oncol. Tumor Pharmacother., 1 (1984) 123.Google Scholar
  8. 8.
    A. Manni, R. Santen, H. Harvey, A. Lipton, D. Max, Endocr. Rev., 7 (1986) 89.Google Scholar
  9. 9.
    S. J. Reshkin, A. Pezzetta, V. Albarani, F. Schittulli, A. Paradiso, Intern. J. Oncol., 7 (1995) 371.Google Scholar
  10. 10.
    M. Fekete, A. Zalatnai, A. M. Comaru-Schally, A. V. Schally, Pancreas, 4 (1989) 521.CrossRefGoogle Scholar
  11. 11.
    A. Paradiso, A. Pezzetta, G. Cellamare, F. Schittulli, F. Marzullo, S. J. Reshkin, J. Endocrinol. Invest., 23 (2000) 90.Google Scholar
  12. 12.
    G. Srkalovic, J. L. Wittliff, A. V. Schally, Cancer Res., 50 (1990) 1841.Google Scholar
  13. 13.
    G. Emons, G. S. Pahwa, G. Brack, R. Sturm, F. Oberheuser, R. Knupperi, Eur. J. Cancer Clin. Oncol., 25 (1989) 215.CrossRefGoogle Scholar
  14. 14.
    M. Fekete, J. L. Wittliff, A. V. Schally, J. Clin. Lab. Anal., 3 (1989) 137.CrossRefGoogle Scholar
  15. 15.
    K. A. Eidne, C. A. Flanagan, N. S. Harris, R. P. Millar, J. Clin. Endocrinol. Metab., 64 (1987) 425.CrossRefGoogle Scholar
  16. 16.
    W. R. Miller, W. N. Scott, R. Morris, N. M. Fraser, R. M. Scarpe, Nature, 313 (1985) 231.CrossRefGoogle Scholar
  17. 17.
    C. A. Flanagan, B. J. Fromme, J. S. Davidson, R. P. Millar, Endocrinol., 139 (1998) 4115.CrossRefGoogle Scholar
  18. 18.
    W. J. Grzegorzewski, J. Skipor, B. Wasowska, T. Krzymowski, Domest. Anim. Endocrinol., 14 (1997) 149.CrossRefGoogle Scholar
  19. 19.
    Y. P. Huang, D. C. Guo, R. E. Peter, Gen. Comp. Endocrinol., 84 (1991) 58.CrossRefGoogle Scholar
  20. 20.
    S. Fasano, R. de Leeuw, R. Pierantoni, G. Chieffi, P. G. van Oordt, Biochem. Biophys. Res. Commun., 168 (1990) 923.CrossRefGoogle Scholar
  21. 21.
    W. R. Huckle, C. A. McArdle, P. M. Conn, J. Biol. Chem., 263 (1988) 3296.Google Scholar
  22. 22.
    Y. Barda, N. Cohen, V. Lev, N. Ben-Aroya, Y. Koch, E. Mishani, M. Fridkin, C. Gilon, Nucl. Med. Biol., 31 (2004) 921.CrossRefGoogle Scholar
  23. 23.
    D. J. Hnatowich, W. W. Layne, R. L. Child, Science, 220 (1983) 613.CrossRefGoogle Scholar
  24. 24.
    W. C. Eckelman, S. M. Karesh, R. C. Reba, J. Pharm. Sci., 64 (1975) 704.CrossRefGoogle Scholar
  25. 25.
    M. A. Green, M. J. Welch, Nucl. Med. Biol., 16 (1989) 435.Google Scholar
  26. 26. Scholar

Copyright information

© Springer Science+Business Media, LLC. 2008

Authors and Affiliations

  • A. R. Jalilian
    • 1
  • S. Shanehsazzadeh
    • 2
  • M. Akhlaghi
    • 1
  • J. Garousi
    • 1
  • S. Rajabifar
    • 1
  • M. B. Tavakoli
    • 2
  1. 1.Nuclear Medicine Group, AgricultureMedicine and Industrial Research School (AMIRS)KarajIran
  2. 2.Department of Biomedical Physics and Engineering, School of MedicineIsfahan University of Medical SciencesIsfahanIran

Personalised recommendations